Pain Medications Following Thyroidectomy and Parathyroidectomy

Sponsor
MetroHealth Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03640247
Collaborator
(none)
126
1
2
12.5
10.1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.

Condition or Disease Intervention/Treatment Phase
  • Drug: Non-narcotic group regimen
  • Drug: Narcotic group regimen
Phase 1

Detailed Description

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen for patients undergoing thyroidectomy and parathyroidectomy. The investigators hypothesize that participants receiving non-narcotic pain regimens will have equivalent pain control and satisfaction to those who receive narcotic pain medicines.

The primary objective will be to identify if there is a difference in average perceived postoperative pain scores between participants who do and do not receive narcotic pain medications. Secondary outcomes will include need for breakthrough pain medications, patient satisfaction scores and the need to call the surgeon office for additional pain medications.

The participant will undergo total thyroidectomy, partial thyroidectomy or parathyroidectomy per the standard of care. The study will have no influence on the surgical procedure performed.

Following the surgery, postoperative analgesia regimens will be prescribed based on study randomization.

Narcotic group regimen (63 patients):
  • Tylenol tablet 1000 mg by mouth every 8 hours alternating with

  • Ibuprofen tablet 800 mg by mouth every 8 hours

  • Oxycodone 5 mg by mouth every 6 hours as needed for pain, #10 tablets

Non-narcotic group regimen (63 patients):
  • Tylenol tablet 1000 mg by mouth every 8 hours alternating with

  • Ibuprofen tablet 800 mg by mouth every 8 hours

Participants will be asked to complete a survey each day for the initial 5 days postoperatively. Survey data includes:

  • Average pain level using the 10-point visual analogue scale

  • Ease of following the pain regimen using a 3-point liker scale

  • Total dose of oral narcotics converted into oral morphine equivalents that were taken by participants post-operatively

  • If the patient needed to call the office due to inadequately controlled pain

If the participants do not have adequate pain control with the non-narcotic regimen, they may be prescribed additional narcotic pain medication at the discretion of the PI and remain enrolled in the study.

The investigators will also review participants charts for information regarding any postoperative office calls regarding postoperative needs (i.e. for pain medications).

The medical surgical information below is gathered as standard of care for each surgical procedure and will also be collected as part of this procedure:

  • Patient name, medical record number

  • Patient demographics (age, gender, BMI, ASA score)

  • Past medical History

  • Past surgical history

  • Past social history

  • Preoperative medications (including steroids, anticoagulation, opioid use)

  • Pre-operative diagnosis

  • Procedure performed and pain medications administered in the post-ambulatory care unit

  • Postoperative complications including need for readmission within 30 days

  • Length of stay in hospital

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
All party or parties involved have knowledge of the interventions assigned to individual participants
Primary Purpose:
Treatment
Official Title:
Are Narcotic Pain Medications Necessary Following Thyroidectomy and Parathyroidectomy
Actual Study Start Date :
Nov 15, 2018
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: Narcotic group regimen

Tylenol tablet 1000 mg by mouth every 8 hours alternating with Ibuprofen tablet 800 mg by mouth every 8 hours Oxycodone 5 mg by mouth every 6 hours as needed for pain, #10 tablet or if needed based on patient allergies, hydrocodone 5 mg/tramadol 50 mg.

Drug: Narcotic group regimen
Narcotic Group: Alternating acetaminophen and ibuprofen, with a prescription of 10 tablets oxycodone (or if needed based on patient allergies, hydrocodone 5 mg/tramadol 50 mg) for break through pain.
Other Names:
  • Ibuprofen 800mg every 8 hours
  • Oxycodone 5mg every 6 hours prn for pain.
  • Hydrocodone 5 mg every 6 hours prn for pain
  • Tramadol 50 mg every 6 hours prn for pain
  • Acetaminophen 500Mg Tab x2 every 8 hours
  • Active Comparator: Non-narcotic group regimen

    Tylenol tablet 1000 mg by mouth every 8 hours alternating with Ibuprofen tablet 800 mg by mouth every 8 hours

    Drug: Non-narcotic group regimen
    Non-Narcotic Group. Receives only alternating acetaminophen and ibuprofen
    Other Names:
  • Ibuprofen 800mg every 8 hours
  • Acetaminophen 500Mg Tab x2 every 8 hours
  • Outcome Measures

    Primary Outcome Measures

    1. Overall mean pain as assessed by 10 point visual analogue scale from the 6 post operative day time points. [Overall mean pain score from 6 time points (Post operative days 0,1,2,3,4,5)]

      10 point visual analogue scale- (0- no pain, 1-3 mild, 4-6 moderate pain, 7-10 severe pain).

    Secondary Outcome Measures

    1. Patient satisfaction with the pain medication regimen as assessed by 3-point likert scale from the 6 post operative day time points. [Mean patient satisfaction score from 6 time points (Post operative days 0,1,2,3,4,5)]

      3 point likert scale (1- easy to manage, 2- manageable but not easy 3- difficult to manage)

    2. Total dose of oral narcotics converted into oral morphine equivalents (see below) that were taken by participants post-operatively [Mean oral morphine equivalents from 6 time points (Post operative days 0,1,2,3,4,5)]

      Oral morphine equivalents(OMEQ): Hydrocodone 5mg =1 OMEQ Oxycodone 5mg = 1.5 OMEQ Hydromorphone 1mg = 4 OMEQ Codeine 5mg = 0.15 OMEQ Tramadol 5mg = 0.20 OMEQ

    3. Mean number of office calls/contacts from the 6 post operative day time points. [Mean number of office calls/contacts from 6 time points (Post operative days 0,1,2,3,4,5)]

      Mean number of office calls/contacts from participants from post operative day 0, 1,2,3,4,5.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18 years or greater

    • Undergoing total thyroidectomy, partial thyroidectomy or parathyroidectomy at MetroHealth Medical Center

    Exclusion Criteria:
    • Patients taking narcotics prior to surgery

    • Patients who are unable or unwilling to follow study protocol requirements

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 MetroHealth Medical Center Cleveland Ohio United States 44109

    Sponsors and Collaborators

    • MetroHealth Medical Center

    Investigators

    • Principal Investigator: Christopher R McHenry, MD, MetroHealth Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Christopher McHenry, MD, Director, Division of General Surgery, MetroHealth Medical Center
    ClinicalTrials.gov Identifier:
    NCT03640247
    Other Study ID Numbers:
    • IRB18-00412
    First Posted:
    Aug 21, 2018
    Last Update Posted:
    Dec 26, 2019
    Last Verified:
    Dec 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Christopher McHenry, MD, Director, Division of General Surgery, MetroHealth Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 26, 2019